National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 24601 [E8-9758]
Download as PDF
Federal Register / Vol. 73, No. 87 / Monday, May 5, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
rfrederick on PROD1PC67 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group, Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: June 12–13, 2008.
Open: June 12, 2008, 5 p.m. to 5:30 p.m.
Agenda: To review procedures and discuss
policy
Place: San Francisco Marriott, 55 Fourth
Street, San Francisco, CA 94103.
Closed: June 12, 2008, 5:30 p.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: San Francisco Marriott, 55 Fourth
Street, San Francisco, CA 94103.
Closed: June 13, 2008, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: San Francisco Marriott, 55 Fourth
Street, San Francisco, CA 94103.
Contact Person: John F. Connaughton, PhD,
Chief, Chartered Committees Section, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7797,
connaughtonj@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group, Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: June 25–26, 2008.
Open: June 25, 2008, 8 a.m. to 8:30 a.m.
Agenda: To review procedures and discuss
policy.
VerDate Aug<31>2005
15:16 May 02, 2008
Jkt 214001
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Closed: June 25, 2008, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Closed: June 26, 2008, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Barbara A. Woynarowska,
PhD, Scientific Review Administrator,
Review Branch, Dea, NIDDK, National
Institutes of Health, Room 754, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 402–7172,
woynarowskab@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: April 28, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–9758 Filed 5–2–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Clinical Trials
Review Committee, June 30, 2008, 8:30
a.m. to July 1, 2008, 5 p.m., Pier 5 Hotel,
711 Eastern Avenue, Baltimore, MD
21202 which was published in the
Federal Register on April 22, 2008,
FRE8–8513.
The meeting dates were changed from
June 30–July 1, 2008 to June 23–24,
2008. Also, meeting location was
changed from Pier 5 Hotel to Sheraton
Columbia Hotel. The rest of the
information remains the same. The
meeting is closed to the public.
Dated: April 28, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–9759 Filed 5–2–08; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
24601
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review of RFA DE–08–006
and RFA DE–08–007 Osteoimmunology—
Crosstalk between Immune System and Bone.
Date: June 3, 2008.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza—Silver Spring, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Rebecca Wagenaar Miller,
PhD, Scientific Review Officer, Scientific
Review Branch, National Inst of Dental &
Craniofacial Research, National Institutes of
Health, 6701 Democracy, Rm 666, Bethesda,
MD 20892, 301–594–0652,
rwagenaa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: April 28, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–9755 Filed 5–2–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
E:\FR\FM\05MYN1.SGM
05MYN1
Agencies
[Federal Register Volume 73, Number 87 (Monday, May 5, 2008)]
[Notices]
[Page 24601]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-9758]
[[Page 24601]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group, Diabetes, Endocrinology
and Metabolic Diseases B Subcommittee.
Date: June 12-13, 2008.
Open: June 12, 2008, 5 p.m. to 5:30 p.m.
Agenda: To review procedures and discuss policy
Place: San Francisco Marriott, 55 Fourth Street, San Francisco,
CA 94103.
Closed: June 12, 2008, 5:30 p.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: San Francisco Marriott, 55 Fourth Street, San Francisco,
CA 94103.
Closed: June 13, 2008, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: San Francisco Marriott, 55 Fourth Street, San Francisco,
CA 94103.
Contact Person: John F. Connaughton, PhD, Chief, Chartered
Committees Section, Review Branch, DEA, NIDDK, National Institutes
of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 594-7797, connaughtonj@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group, Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: June 25-26, 2008.
Open: June 25, 2008, 8 a.m. to 8:30 a.m.
Agenda: To review procedures and discuss policy.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Closed: June 25, 2008, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Closed: June 26, 2008, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Barbara A. Woynarowska, PhD, Scientific Review
Administrator, Review Branch, Dea, NIDDK, National Institutes of
Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 402-7172, woynarowskab@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: April 28, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-9758 Filed 5-2-08; 8:45 am]
BILLING CODE 4140-01-M